FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma
Season 9, Episode 24, Sep 07, 2023, 06:00 PM
Dr Minnema discusses the FDA approval of talquetamab in patients with relapsed/refractory multiple myeloma, key data from the MonumenTAL-1 trial, and the importance of designing clinical trials to address unmet patient needs.